Clinical Trial Update: Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating intraarticular IL-1 receptor antagonist for pain and inflammatory mediators after knee arthroscopy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Injuries

Snippet

Sponsor: Oslo University Hospital | Conditions: Knee Injuries | Phase 4 | Status: WITHDRAWN